Harnessing human mobility and surveillance data for disease forecasting to drive evidence-based public health policy during the COVID-19 epidemic

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:239 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $506,100
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    University Health Network
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-19 emerged from Wuhan, China in late December 2019 and is currently spreading to international destinations, globally. At the time of writing, cases have been confirmed in 24 countries worldwide. Of major concern are early indications of human-to-human transmission outside of China in those without a travel history to China. During the two months of this epidemic, public health policy has adapted rapidly to emerging information about disease location, disease burden, and clinical features of COVID-19. Public health screening and interventions will need to continuously evolve over the course of this epidemic to keep up with new foci of infection and potential new regions of COVID-19 exportation. We aim to harness validated tools to predict where COVID-19 will spread in real time by using a novel, AI-driven web-based surveillance tool coupled with real-time human mobility data. This surveillance system identifies regions with real or suspected cases of COVID-19. We simultaneously harness global commercial air transportation data and geo-referenced mobile device data to reflect human mobility, also in real time. We have successfully validated these tools for COVID-19 forecasting during the course of this epidemic and published our results in peer-reviewed literature. We will first use the AI-based surveillance system to identify regions with confirmed and suspected COVID-19 cases. We will then model the spread of infection from these locations by harnessing human mobility data to identify and forecast new regions (at the city, regional, and national level) for virus importation. We will work closely with our partners in the World Health Organization, the Association of South East Asian Nations (ASEAN), and the International Air Transport Association (IATA) to use this data to help drive evidence-based public health policy in real time, with a focus on global projection strategies, and strategies for low and middle income countries in Southeast Asia.

Publicationslinked via Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Identification and Characterization of a Rare Exon 22 Duplication in <i>CFTR</i> in Two Families.

Structural Rearrangement in Cyclic Cu(II) Pyridyltriazole Complexes: Oxidation of Dabco to Oxalate and CO<sub>2</sub> Conversion to Carbonate.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.